Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Kidney cancer is a malignant tumor originating in the kidney, mainly affecting middle-aged and elderly people. If not treated in time, it can quickly progress and metastasize, posing a serious threat to life. Currently, kidney cancer treatment methods are diverse, and if patients miss the treatment window, disease control becomes very difficult and survival is greatly shortened.
Immune reconstruction cell therapy enhances the patient’s immune system to recognize and attack cancer cells, improving treatment efficacy. This therapy has the following advantages for kidney cancer:
① Enhances immune cell activity and increases tumor clearance rate
② Reduces recurrence risk and improves long-term survival quality
③ Reduces side effects of traditional treatments and improves patient tolerance
This innovative therapy brings new hope to kidney cancer patients, especially for middle- to late-stage or recurrent cases.
During actual treatment, cancer patients receiving surgery, radiotherapy, and chemotherapy often face impaired immune function, increased infection risk, and slow recovery. To better support patients through treatment, improve tolerance, and enhance survival quality, it is necessary to scientifically design phased immune reconstruction plans across different treatment cycles.
● Short-term Plan: Rapidly enhance immunity through immune cell reinfusion, boosting the effectiveness of anti-cancer treatment.
● Mid-term Plan: Reduce side effects of traditional treatments, promote physical recovery, and complete standardized treatment courses.
● Long-term Plan: Enhance overall immunity through immune cell reconstruction, gut immune reconstruction, elemental immune reconstruction, and immune nutrition reconstruction, thereby improving quality of life and extending survival.
1. Surgical Treatment
Surgery is the main curative approach for kidney cancer, including partial nephrectomy and radical nephrectomy. Early tumors achieve the best results with surgical removal. As surgical methods continue to advance, recovery has become significantly faster. Surgery remains the preferred curative option for many patients.
2. Targeted Therapy
Targeted drugs act on tumor growth signaling pathways to inhibit cancer cell proliferation. They are suitable for advanced patients and those who cannot undergo surgery. Commonly used drugs include tyrosine kinase inhibitors, which can effectively delay disease progression.
3. Radiotherapy and Chemotherapy
Kidney cancer is relatively resistant to traditional radiotherapy and chemotherapy, but in some metastatic cases, radiotherapy can relieve symptoms, and chemotherapy is used as an adjuvant treatment to improve overall efficacy.
4. Minimally Invasive Treatment
With technological advances, minimally invasive techniques such as laparoscopic nephrectomy, radiofrequency ablation, and cryoablation have been gradually applied in clinical practice. They cause less trauma, allow faster recovery, and are suitable for some early-stage patients.
5. Cryoablation
Under CT guidance, a probe is inserted into the tumor, and cancer cells are frozen and thawed at -140°C with liquid nitrogen. This method is suitable for elderly patients with kidney cancer who cannot tolerate surgery. It is performed under local anesthesia and preserves renal parenchyma.
6. Radiofrequency Ablation
An electrode needle is percutaneously inserted, and the tumor is coagulated at 90–110°C. It is suitable for lesions ≤3 cm in the posterior renal calyx, avoiding nephrectomy. It is contraindicated for lesions near the intestine or ureter.
7. Targeted Embolization
A super-selective catheter is inserted into the renal tumor’s feeding artery, and drug-loaded microspheres are injected to embolize the blood vessels. This is used for late-stage treatment, shrinking tumors, and, when combined with immunotherapy, prolonging survival.
Kidney cancer treatment requires individualized plans based on the patient’s condition. Experts at United Life International Medical Center emphasize that combining immune reconstruction cell therapy with surgery, targeted therapy, and minimally invasive treatments will significantly improve prognosis and quality of life. Timely standardized treatment is the key to overcoming kidney cancer.
